All PharmGKB pathways
PharmGKB · ClinPGx

Pentose Phosphate Pathway (Erythrocyte), Pharmacodynamics

PA165971634 Last updated September 2012
5/12
Drugs & chemicals
0
Genes
0/0
Conditions
27
Reactions
Pentose Phosphate Pathway (Erythrocyte), Pharmacodynamics pathway diagram
Pentose Phosphate Pathway (Erythrocyte), Pharmacodynamics — pathway diagram from PharmGKB / ClinPGx
Click to enlarge

About this pathway

The Pentose Phosphate Pathway (PPP) and production of NADPH in red blood cells

Glucose is converted to glucose-6-phosphate by hexokinase (HK1), and then enters either the glycolysis pathway via conversion to the isomer fructose-6-phosphate, or the PPP (also known as hexose monophosphate shunt) via oxidation into 6-phosphogluconolactone [Articles:18177777, 16204390, 21376665, 18226191, 17489100, 13799836, 15862084, 9531504]. Two steps within the PPP produce NADPH; the conversion of glucose-6-phosphate to 6-phosphogluconolactone by G6PD, and 6-phosphogluconate to ribulose-5-phosphate by 6-phosphogluconate dehydrogenase (PGD, 6PGD) [Articles:18177777, 16204390, 18226191, 21376665, 20350285]. The end product of the pathway is ribose-5-phosphate, utilized for the production of nucleotides, polysaccharides and coenzymes, and used in RBCs for phosphoribosylpyrophosphate (PRPP) production to generate ADP for use in the Embden-Meyerhof glycolysis pathway [Articles:21376665, 20122995, 7713590]. NADPH is required in the RBC for the regulation of oxidative stress and within the methylene blue pathway [Articles:21376665, 7489710, 7073040]. The only source of NADPH in RBCs is via the PPP, in which G6PD is the rate-limiting step [Articles:16204390, 2633878, 18177777, 4154443, 15862084, 21376665]. As RBCs age, enzyme activities involved in glucose metabolism diminish, including G6PD, reducing energy production and ability to protect cell membrane integrity and hemoglobin from oxidation [Articles:14074568, 13799836].

Reactions & interactions (27)

  • Activation
    fructose-6-phosphate ribose phosphate
  • Biochemical Reaction
    ribose phosphate phosphoribosyl pyrophosphate
  • Biochemical Reaction
    glucose glucose-6-phosphate
  • Biochemical Reaction
    6-phosphogluconate ribulose-5-phosphate
  • Biochemical Reaction
    ribulose-5-phosphate ribose phosphate
  • Biochemical Reaction
    6-phosphogluconolactone 6-phosphogluconate
  • Biochemical Reaction
    Nicotinamide adenine dinucleotide phosphate Dihydronicotinamide adenine dinucleotide phosphate
  • Biochemical Reaction
    Nicotinamide adenine dinucleotide phosphate Dihydronicotinamide adenine dinucleotide phosphate
  • Biochemical Reaction
    glucose-6-phosphate fructose-6-phosphate
  • Biochemical Reaction
    glucose-6-phosphate 6-phosphogluconolactone
  • Biochemical Reaction
    fructose-6-phosphate glucose-6-phosphate
  • Biochemical Reaction
    adenine + phosphoribosyl pyrophosphate adenosine diphosphate
  • Catalysis
    HK1 Biochemical Reaction
  • Catalysis
    PGD Biochemical Reaction
  • Catalysis
    PGLS Biochemical Reaction
  • Catalysis
    PGD Biochemical Reaction
  • Catalysis
    SLC2A1 Transport
  • Catalysis
    G6PD Biochemical Reaction
  • Catalysis
    GPI Biochemical Reaction
  • Catalysis
    G6PD Biochemical Reaction
  • Leads To
    fructose-6-phosphate glycolysis
  • Leads To
    Dihydronicotinamide adenine dinucleotide phosphate Methylene Blue Pathway, Pharmacodynamics
  • Leads To
    Dihydronicotinamide adenine dinucleotide phosphate Methylene Blue Pathway, Pharmacodynamics
  • Leads To
    Dihydronicotinamide adenine dinucleotide phosphate Oxidative Stress Regulatory Pathway (Erythrocyte)
  • Leads To
    adenosine diphosphate glycolysis
  • Leads To
    Dihydronicotinamide adenine dinucleotide phosphate Oxidative Stress Regulatory Pathway (Erythrocyte)
  • Transport
    glucose glucose

Edit history (1)

  • 2012-09-07 Create
Pentose Phosphate Pathway (Erythrocyte), Pharmacodynamics pathway diagram (enlarged)